MyAverix Finance
US · Healthcare
Arbutus Biopharma Corp (ABUS)
Biotechnology
Arbutus Biopharma Corp (ABUS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ABUS
Arbutus Biopharma Corp (ABUS) — FAQ
What is ABUS's P/E ratio?
The price-to-earnings (P/E) ratio for Arbutus Biopharma Corp (ABUS) is 25.00 (data as of 2026-05-23).
Does Arbutus Biopharma Corp pay a dividend?
Dividend yield is not available in the current snapshot for Arbutus Biopharma Corp (ABUS). Check the MyAverix Finance app for the latest dividend data.
What sector is Arbutus Biopharma Corp in?
Arbutus Biopharma Corp (ABUS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ABUS listed on?
ABUS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.